Concordance between sudomotor disorder and the clinical diagnosis of diabetic peripheral neuropathy, according to various clinical guidelines

      Highlights

      • Neuropad is an instrument facilitating self-examination of the foot.
      • Neuropad enable the diagnosis of DPN and its use could help reduce the risk of plantar ulcers.
      • It is an indicator test for the assessment of sweating in the feet of patients with diabetes.

      Abstract

      Aim

      To assess the concordance between variations in Neuropad® results and the those in different diagnostic criteria of Diabetic Peripheral Neuropathy, according to various clinical guidelines.

      Methods

      A descriptive observational study was conducted of 111 patients with a confirmed diagnosis of diabetes mellitus. The criteria for inclusion in the study were that patients should be aged 18 years or more and have at least 10 years’ history of diabetes mellitus.

      Results

      73 (65.8%) were male and 38 (34.2%) were female. Their mean age was 57.92 ± 13.24 years (95% CI 55.45–60.38). Healthy Neuropad® findings were obtained for 35 right feet (31.5%) and 31 left feet (27.9%).

      Conclusion

      Neuropad® is an effective instrument for detecting macro and microvascular complications such as early-stage neuropathy, although its use should always be accompanied by a clinical examination of the foot.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Edición S.
        Atlas de la DIABETES de la FID.
        2015
        • Marcial E.
        • Graves B.A.
        Implementation and evaluation of diabetes clinical practice guidelines in a primary care clinic serving a Hispanic community.
        Worldviews Evid. Based Nurs. 2019; 16: 142-150https://doi.org/10.1111/wvn.12345
        • Macfarlane R.M.
        • Jeffcoate W.J.
        Factors contributing to the presentation of diabetic foot ulcers.
        Diabet. Med. 1997; 14: 867-870https://doi.org/10.1002/(SICI)1096-9136(199710)14:10<867::AID-DIA475>3.0.CO;2-L
        • van Netten J.J.
        • Raspovic A.
        • Lavery L.A.
        • Monteiro-Soares M.
        • Rasmussen A.
        • Sacco I.C.N.
        • Bus S.A.
        Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review.
        Diabetes Metab. Res. Rev. 2020; 36e3270https://doi.org/10.1002/dmrr.3270
        • Crawford F.
        • Cezard G.
        • Chappell F.M.
        • Murray G.D.
        • Price J.F.
        • Sheikh A.
        • Simpson C.R.
        • Stansby G.P.
        • Young M.J.
        A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS).
        Health Technol. Assess. (Rockv). 2015; 19: 1-207https://doi.org/10.3310/hta19570
        • Chicharro-Luna E.
        • Pomares-Gómez F.J.
        • Ortega-Ávila A.B.
        • Marchena-Rodríguez A.
        • Blanquer-Gregori J.F.J.
        • Navarro-Flores E.
        Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus.
        Int. Wound J. 2020; 17: 220-227https://doi.org/10.1111/iwj.13263
        • Lechner A.
        • Akdeniz M.
        • Tomova-Simitchieva T.
        • Bobbert T.
        • Moga A.
        • Lachmann N.
        • Blume-Peytavi U.
        • Kottner J.
        Comparing skin characteristics and molecular markers of xerotic foot skin between diabetic and non-diabetic subjects: an exploratory study.
        J. Tissue Viability. 2019; 4: 200-209https://doi.org/10.1016/j.jtv.2019.09.004
        • Kempler P.
        • Amarenco G.
        • Freeman R.
        • Frontoni S.
        • Horowitz M.
        • Stevens M.
        • Low P.
        • Pop-Busui R.
        • Tahrani A.A.
        • Tesfaye S.
        • Várkonyi T.
        • Ziegler D.
        • Valensi P.
        Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes.
        Diabetes Metab. Res. Rev. 2011; 27: 665-677https://doi.org/10.1002/dmrr.1223
        • Boulton A.J.M.
        • Armstrong D.G.
        • Albert S.F.
        • Frykberg R.G.
        • Hellman R.
        • Kirkman M.S.
        • Lavery L.A.
        • Lemaster J.W.
        • Mills J.L.
        • Mueller M.J.
        • Sheehan P.
        • Wukich D.K.
        Comprehensive foot examination and risk assessment.
        Diabetes Care. 2008; 31: 1679-1685https://doi.org/10.2337/dc08-9021
        • Chicharro-Luna E.
        • Pomares-Gómez F.J.
        • Ortega-Ávila A.B.
        • Coheña-Jiménez M.
        • Gijon-Nogueron G.
        Variability in the clinical diagnosis of diabetic peripheral neuropathy.
        Prim. Care Diabetes. 2020; 14: 53-60https://doi.org/10.1016/j.pcd.2019.05.008
        • Tesfaye S.
        • Boulton A.J.M.
        • Dyck P.J.
        • Freeman R.
        • Horowitz M.
        • Kempler P.
        • Lauria G.
        • Malik R.A.
        • Spallone V.
        • Vinik A.
        • Bernardi L.
        • Valensi P.
        • Albers J.W.
        • Amarenco G.
        • Anderson H.
        • Arezzo J.
        • Backonja M.M.
        • Biessels G.J.
        • Bril V.
        • Cameron N.
        • Cotter M.
        • England J.
        • Feldman E.
        • Frontoni S.
        • Hilsted J.
        • Low P.
        • Malik R.
        • O’Brien P.C.
        • Pop-Busui R.
        • Perkins B.
        • Rayman G.
        • Russell J.
        • Sindrup S.
        • Smith G.
        • Stevens M.
        • Várkonyi T.
        • Veves A.
        • Vileikyte L.
        • Ziegler D.
        • Zochodne D.
        • Jones T.
        Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.
        Diabetes Care. 2010; 33: 2285-2293https://doi.org/10.2337/dc10-1303
        • Papanas N.
        • Ziegler D.
        New diagnostic tests for diabetic distal symmetric polyneuropathy.
        J. Diabetes Complications. 2011; 25: 44-51https://doi.org/10.1016/j.jdiacomp.2009.09.006
        • Papanas N.
        • Boulton A.J.M.
        • Malik R.A.
        • Manes C.
        • Schnell O.
        • Spallone V.
        • Tentolouris N.
        • Tesfaye S.
        • Valensi P.
        • Ziegler D.
        • Kempler P.
        A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy.
        Diabet. Med. 2013; 30: 525-534https://doi.org/10.1111/dme.12000
        • Quattrini C.
        • Jeziorska M.
        • Tavakoli M.
        • Begum P.
        • Boulton A.J.M.
        • Malik R.A.
        The Neuropad test: a visual indicator test for human diabetic neuropathy.
        Diabetologia. 2008; 51: 1046-1050https://doi.org/10.1007/s00125-008-0987-y
        • Tentolouris N.
        • Achtsidis V.
        • Marinou K.
        • Katsilambros N.
        Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes.
        Diabetes Care. 2008; 31: 236-237https://doi.org/10.2337/dc07-1942
        • Ziegler D.
        • Papanas N.
        • Rathmann W.
        • Heier M.
        • Scheer M.
        • Meisinger C.
        Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey.
        Diabetes Metab. Res. Rev. 2012; 28: 692-697https://doi.org/10.1002/dmrr.2340
        • Spallone V.
        • Morganti R.
        • Siampli M.
        • Fedele T.
        • D’Amato C.
        • Cacciotti L.
        • Maiello M.R.
        Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
        Diabet. Med. 2009; 26: 686-692https://doi.org/10.1111/j.1464-5491.2009.02760.x
        • Selvarajah D.
        • Cash T.
        • Davies J.
        • Sankar A.
        • Rao G.
        • Grieg M.
        • Pallai S.
        • Gandhi R.
        • Wilkinson I.D.
        • Tesfaye S.
        SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy.
        PLoS One. 2015; 10e0138224https://doi.org/10.1371/journal.pone.0138224
        • Ayoub H.
        • Lair V.
        • Griveau S.
        • Brunswick P.
        • Bédioui F.
        • Cassir M.
        SUDOSCAN device for the early detection of diabetes: in vitro measurement versus results of clinical tests.
        Sens. Lett. 2011; 9: 2147-2149https://doi.org/10.1166/sl.2011.1756
        • Papanas N.
        • Papatheodorou K.
        • Christakidis D.
        • Papazoglou D.
        • Giassakis G.
        • Piperidou H.
        • Monastiriotis C.
        • Maltezos E.
        Evaluation of a new indicator test for sudomotor function (Neuropad®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
        Exp. Clin. Endocrinol. Diabetes. 2005; 113: 195-198https://doi.org/10.1055/s-2005-837735
        • Pickering T.G.
        • Hall J.E.
        • Appel L.J.
        • Falkner B.E.
        • Graves J.
        • Hill M.N.
        • Jones D.W.
        • Kurtz T.
        • Sheps S.G.
        • Roccella E.J.
        Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans — a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Co.
        Circulation. 2005; 111: 697-716https://doi.org/10.1161/01.CIR.0000154900.76284.F6
        • Ziegler D.
        • Papanas N.
        • Roden M.
        Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes.
        Diabet. Med. 2011; 28: 1412-1415https://doi.org/10.1111/j.1464-5491.2011.03345.x
        • Bilen H.
        • Atmaca A.
        • Akcay G.
        Neuropad® indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes.
        Adv. Ther. 2007; 24: 1020-1027https://doi.org/10.1007/BF02877707
        • Grandinetti A.
        • Chow D.C.
        • Sletten D.M.
        • Oyama J.K.
        • Theriault A.G.
        • Schatz I.J.
        • Low P.A.
        Impaired glucose tolerance is associated with postganglionic sudomotor impairment.
        Clin. Auton. Res. 2007; 17: 231-233https://doi.org/10.1007/s10286-007-0426-z
        • Papanas N.
        • Papatheodorou K.
        • Papazoglou D.
        • Christakidis D.
        • Monastiriotis C.
        • Maltezos E.
        Reproducibility of the new indicator test for sudomotor function (Neuropad®) in patients with type 2 diabetes mellitus: short communication.
        Exp. Clin. Endocrinol. Diabetes. 2005; 113: 577-581https://doi.org/10.1055/s-2005-872912
        • aan de Stegge W.B.
        • Mejaiti N.
        • van Netten J.J.
        • Dijkgraaf M.G.W.
        • van Baal J.G.
        • Busch-Westbroek T.E.
        • Bus S.A.
        The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial.
        Trials. 2018; 19: 520https://doi.org/10.1186/s13063-018-2890-2
        • Papanas N.
        • Papatheodorou K.
        • Papazoglou D.
        • Kotsiou S.
        • Maltezos E.
        Association between foot temperature and sudomotor dysfunction in type 2 diabetes.
        J. Diabetes Sci. Technol. 2010; 4: 803-807https://doi.org/10.1177/193229681000400406
        • Sun P.C.
        • Lin H.D.
        • Jao S.H.
        • Chan R.C.
        • Kao M.J.
        • Cheng C.K.
        Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet.
        Diabet. Med. 2008; 25: 413-418https://doi.org/10.1111/j.1464-5491.2008.02395.x
        • Jung D.
        • Bin Kim Y.
        • Lee J.B.
        • Muhamed A.M.C.
        • Lee J.Y.
        Sweating distribution and active sweat glands on the scalp of young males in hot-dry and hot-humid environments.
        Eur. J. Appl. Physiol. 2018; 118: 2655-2667https://doi.org/10.1007/s00421-018-3988-7
        • Kamenov Z.A.
        • Christov V.G.
        • Yankova T.M.
        Erectile dysfunction in diabetic men is linked more to microangiopathic complications and neuropathy than to macroangiopathic disturbances.
        J. Mens. Health Gend. 2007; 4https://doi.org/10.1016/j.jmhg.2006.12.004
        • Eranki V.G.
        • Santosh R.
        • Rajitha K.
        • Pillai A.
        • Sowmya P.
        • Dupin J.
        • Calvet J.H.
        Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes.
        Diabetes Res. Clin. Pract. 2013; 101: 11-13https://doi.org/10.1016/j.diabres.2013.07.003
        • Shivaprasad C.
        • Amit G.
        • Anish K.
        • Rakesh B.
        • Anupam B.
        • Aiswarya Y.
        Clinical correlates of sudomotor dysfunction in patients with type 2 diabetes and peripheral neuropathy.
        Diabetes Res. Clin. Pract. 2018; 139: 188-194https://doi.org/10.1016/j.diabres.2018.03.004
        • Kamenov Z.A.
        • Petrova J.J.
        • Christov V.G.
        Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (Neuropad®) tests in the clinical practice.
        Exp. Clin. Endocrinol. Diabetes. 2010; 118: 226-233https://doi.org/10.1055/s-0030-1247565
        • Yoshioka K.
        • Okada H.
        Useful application of the neuropad test for assessment of diabetic polyneuropathy.
        Intern. Med. 2012; 51: 3241-3245https://doi.org/10.2169/internalmedicine.51.8366
        • Papanas N.
        • Papatheodorou K.
        • Papazoglou D.
        • Monastiriotis C.
        • Christakidis D.
        • Maltezos E.
        A comparison of the new indicator test for sudomotor function (Neuropad®) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
        Exp. Clin. Endocrinol. Diabetes. 2008; 116: 135-138https://doi.org/10.1055/s-2007-984455
        • Didangelos T.
        • Zografou I.
        • Iliadis F.
        • Sambanis C.
        Validation of Neuropad in the assessment of peripheral diabetic neuropathy in patients with diabetes mellitus versus the Michigan neuropathy screening instrument, 10 g monofilament application and biothesiometer measurement.
        Curr. Vasc. Pharmacol. 2019; 18: 517-522https://doi.org/10.2174/1570161117666190723155324
        • Rodríguez-Sánchez B.
        • Peña-Longobardo L.M.
        • Sinclair A.J.
        Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
        Eur. J. Health Econ. 2019; 21: 335-349https://doi.org/10.1007/s10198-019-01134-2